Cycode Leads Code to Cloud Shift with 200% Y-o-Y Revenue Growth
01 août 2023 09h00 HE
|
Cycode
SAN FRANCISCO, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Cycode, the leading Application Security Posture Management (ASPM) platform for code to cloud, today announced its 200% year-over-year revenue growth...
Canon Business Process Services Announces New Executive Appointments
05 juil. 2023 14h41 HE
|
Canon U.S.A., Inc.
New York, NY, July 05, 2023 (GLOBE NEWSWIRE) -- Canon Business Process Services, a wholly owned subsidiary of Canon U.S.A., Inc., announces two executive appointments that took effect July 1. These...
Canon U.S.A., Inc. Announces New Executive Appointments
05 juil. 2023 12h50 HE
|
Canon U.S.A., Inc.
MELVILLE, NY, July 05, 2023 (GLOBE NEWSWIRE) -- Canon U.S.A., Inc., a leader in digital imaging solutions, is proud to announce executive appointments and promotions that took effect July 1. These...
Angus Gold Strengthens its Board and Management Team
28 juin 2023 07h30 HE
|
Angus Gold Inc.
Highlights: David Palmer appointed as Chairman and Director of the CompanyBreanne Beh appointed President and CEO, effective July 10, 2023Appointments are part of the Company’s initiative to build...
VEON Appoints Omiyinka Doris Group General Counsel
16 juin 2023 04h34 HE
|
VEON Ltd.
VEON Appoints Omiyinka Doris Group General Counsel Amsterdam, 16 June 2023 – VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and...
NRG Therapeutics Appoints Dr Jonathan Savidge as Independent Chair
26 avr. 2023 04h00 HE
|
NRG Therapeutics Limited
STEVENAGE, United Kingdom, April 26, 2023 (GLOBE NEWSWIRE) -- NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has...
NRG Therapeutics Appoints Vad Lazari Ph.D. as Vice President of Biology to Advance its Mitochondrial Therapeutics for Neurodegenerative Disorders
19 avr. 2023 04h00 HE
|
NRG Therapeutics Limited
Vad Lazari Ph.D., appointed to the newly created position of VP of Biology, based in Stevenage, UKJoins from Charles River and brings two decades of drug discovery experience including at Pfizer and...
NRG Therapeutics Announces International Scientific Advisory Board
30 mars 2023 04h00 HE
|
NRG Therapeutics Limited
STEVENAGE, United Kingdom, March 30, 2023 (GLOBE NEWSWIRE) -- NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce the formation of...
MitoRx Therapeutics Announces Scientific Advisory Board, Chief Development Officer and Finance Director
07 mars 2023 03h00 HE
|
MitoRx Therapeutics
OXFORD, England, March 07, 2023 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing revolutionary therapeutics that reverse mitochondrial dysfunction to arrest the...
NRG Therapeutics Appoints Gilles Ouvry Ph.D. as Vice President of Chemistry to Advance its Mitochondrial Therapeutics for Neurodegenerative Disorders
09 févr. 2023 04h01 HE
|
NRG Therapeutics Limited
Gilles Ouvry Ph.D, appointed to newly created position of VP of Chemistry, based in Stevenage, UKJoins from Evotec, UK and brings 20 years of international medicinal chemistry experience including at...